EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention

Winston L McCormick iD, Gail Jackson, Sarah B Andrea iD, Valerie Whitehead, Tiffany L Chargualaf, Francine Touzard-Romo

Infection Control & Hospital Epidemiology · 2024

DOI: 10.1017/ice.2023.92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Winston L McCormick und 5 weiteren Autor:innen. Beteiligte Einrichtung: Warren Alpert Medical School of Brown University, Providence, Rhode Island. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Cross Infection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Misclassification of Clostridioides difficile colonization as hospital-onset C. difficile infection (HO-CDI) can lead to unnecessary treatment of patients and substantial financial penalties for hospitals. We successfully implemented mandatory C. difficile PCR testing approval as a strategy to optimize testing, which was associated with a significant decline in the monthly incidence of HO-CDI rates and lowering of our standardized infection ratio to 0.77 (from 1.03) 18 months after this intervention. Approval request served as an educational opportunity to promote mindful testing and accurate diagnosis of HO-CDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileClostridium InfectionsCross InfectionHumansHospitalsNucleic Acid Amplification Techniques

Autor:innen und Institutionen

  • Warren Alpert Medical School of Brown University, Providence, Rhode Island.
  • Department of Infection Control, Newport Hospital, Newport, Rhode Island.
  • OHSU-PSU School of Public Health, Portland, Oregan.
  • Lifespan Biostatistics Epidemiology and Research Design Core, Rhode Island Hospital, Rhode Island.
  • Lifespan Clinical Microbiology Laboratory, Providence, Rhode Island.
  • Division of Infectious Diseases, Alpert Medical School of Brown University, Providence, Rhode Island.

ORCID-Profile: Winston L McCormick, Sarah B Andrea

Zitieren

APA

McCormick, W. L., Jackson, G., Andrea, S. B., Whitehead, V., Chargualaf, T. L., & Touzard-Romo, F. (2024). Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2023.92

Vancouver

McCormick WL, Jackson G, Andrea SB, Whitehead V, Chargualaf TL, Touzard-Romo F. Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2023.92

BibTeX
@article{McCormick2024,
  author = {McCormick, Winston L and Jackson, Gail and Andrea, Sarah B and Whitehead, Valerie and Chargualaf, Tiffany L and Touzard-Romo, Francine},
  title = {Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention},
  journal = {Infection Control & Hospital Epidemiology},
  year = {2024},
  doi = {10.1017/ice.2023.92}
}
Kostenlos starten →